SCM
LUMO

Sigma Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Sigma Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-8,333
Closed -$1.48M – 370
2013
Q2 		$1.48M Buy
+8,333
New +$1.18M 0.07% 196

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sigma Capital Management's LUMO Position: Q3 2013 in Review

Sigma Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2013, closing a stake of 8,333 shares — an estimated $1.48M sold.

Sigma Capital Management first reported a position in LUMO in Q2 2013 and held it in 1 quarter. The position peaked at $1.48M in Q2 2013. 71 funds tracked by Wall St. Rank hold LUMO as of Q3 2013.

  • Sigma Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
  • Sigma Capital Management sold 8,333 Lumos Pharma, Inc. Common Stock shares in Q3 2013, an estimated $1.48M.
  • Sigma Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
  • Sigma Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $1.48M in Q2 2013.
  • 71 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2013.

Based on Sigma Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.